Skip to main content
FinSpry Logo
FinSpry
TGTX logo
TGTX
(NASDAQ)
TG Therapeutics, Inc.
$55.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

TG Therapeutics (TGTX) Stock Price & Financial Analysis

TG Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$51.28 - $55.59
52-Week High$59.30
52-Week Low$25.28
Open$52.26
Volume2.96M
Average Volume (3M)2.73M
Market Cap8.88B
Shares Outstanding160.06M
P/E Ratio (TTM)19.23
Forward P/E9.66
Price to Sales (P/S)12.68
Price to Book (P/B)15.23
EV/EBITDA62.40
Revenue (TTM)700.35M
Net Income (TTM)461.90M
Free Cash Flow (TTM)-14.19M
EPS (TTM)$2.87
Profit Margin65.95%
Operating Margin21.35%
Return on Equity (ROE)79.21%
Debt to Equity1.29
50-Day MA$48.30
200-Day MA$36.11
52-Week Change47.61%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About TG Therapeutics

What is the current stock price for TGTX?

As of the latest trading session, TGTX stock trades at $55.50. The 52-week range is $25.28–$59.30, with a day range of $51.28–$55.59.

What is the P/E ratio for TGTX?

TG Therapeutics's trailing P/E ratio is 19.2, meaning investors pay $19.2 for every $1 of annual earnings. The forward P/E is 9.7, reflecting analyst expectations for future earnings. TG Therapeutics operates in the Healthcare sector.

Does TGTX pay dividends?

TG Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TGTX?

Based on 7 analysts, the consensus for TGTX is Buy.

What is the market cap of TGTX?

TG Therapeutics's market capitalization is $8.88B, classifying it as a mid-cap company. TG Therapeutics operates in the Healthcare sector within the Biotechnology industry.